The OxStu discusses the causes and implications of antimicrobial resistance, and the social and scientific methods to combat ...

A vaccine targeting gonorrhea will soon be rolled out on the NHS. This will make England and Wales the first two countries in ...

Swiss pharmaceutical company Roche has announced that a new antibiotic, zosurabalpin, is progressing to phase 3 testing.

Stat: A Case Study In The Fast-Rising Threat Of Antibiotic Resistance In the good old days — way back in early 2012 — people who contracted gonorrhea were given a single pill to cure the infection. A ...

Gepotidacin was non-inferior to ceftriaxone plus azithromycin for the primary outcome of microbiological success. 2. There were no serious or treatment-related adverse events in either group. Evidence ...

The Swiss drugmaker says the safety and efficacy of zosurabalpin will be investigated in a study involving 400 patients with ...

Debiopharm initially received funding from CARB-X in 2017 for pre-clinical development of Debio1453, which inhibits an ...

INRAE scientists have identified seven bacteria involved in the microbiota barrier effect, which prevents pathogenic bacteria ...

Debiopharm ( a privately-owned, Swiss-based biopharmaceutical company aiming to establish tomorrow’s standard-of-care to cure ...